AAAAAA

   
Results: 1-17 |
Results: 17
Squalamine treatment of human tumors in nu/nu mice enhances platinum-basedchemotherapies
Authors: Williams, JI Weitman, S Gonzalez, CM Jundt, CH Marty, J Stringer, SD Holroyd, KJ McLane, MP Chen, QM Zasloff, M Von Hof, DD
Citation: Ji. Williams et al., Squalamine treatment of human tumors in nu/nu mice enhances platinum-basedchemotherapies, CLIN CANC R, 7(3), 2001, pp. 724-733
A phase I study of irinotecan in pediatric patients: A Pediatric Oncology Group Study
Authors: Blaney, S Berg, SL Pratt, C Weitman, S Sullivan, J Luchtman-Jones, L Bernstein, M
Citation: S. Blaney et al., A phase I study of irinotecan in pediatric patients: A Pediatric Oncology Group Study, CLIN CANC R, 7(1), 2001, pp. 32-37
Exploring the mechanisms of action of FB642 at the cellular level
Authors: Hammond, LA Davidson, K Lawrence, R Camden, JB Von Hoff, DD Weitman, S Izbicka, E
Citation: La. Hammond et al., Exploring the mechanisms of action of FB642 at the cellular level, J CANC RES, 127(5), 2001, pp. 301-313
Biodegradable block copolymers for delivery of proteins and water-insoluble drugs
Authors: Zentner, GM Rathi, R Shih, C McRea, JC Seo, MH Oh, H Rhee, BG Mestecky, J Moldoveanu, Z Morgan, M Weitman, S
Citation: Gm. Zentner et al., Biodegradable block copolymers for delivery of proteins and water-insoluble drugs, J CONTR REL, 72(1-3), 2001, pp. 203-215
A phase I study of cranial radiation therapy with concomitant continuous infusion paclitaxel in children with brain tumors
Authors: Liu, L Vapiwala, N Munoz, LK Winick, NJ Weitman, S Strauss, LC Frankel, LS Rosenthal, DI
Citation: L. Liu et al., A phase I study of cranial radiation therapy with concomitant continuous infusion paclitaxel in children with brain tumors, MED PED ONC, 37(4), 2001, pp. 390-392
The new dioxolane, (-)-2 '-deoxy-3 '-oxacytidine (BCH-4556, troxacitabine), has activity against pancreatic human tumor xenografts
Authors: Weitman, S Marty, J Jolivet, J Locas, C Von Hoff, DD
Citation: S. Weitman et al., The new dioxolane, (-)-2 '-deoxy-3 '-oxacytidine (BCH-4556, troxacitabine), has activity against pancreatic human tumor xenografts, CLIN CANC R, 6(4), 2000, pp. 1574-1578
MGI 114: Augmentation of antitumor activity when combined with topotecan
Authors: Weitman, S Barrera, H Moore, R Gonzalez, C Marty, J Hilsenbeck, S MacDonald, JR Waters, SJ Von Hoff, D
Citation: S. Weitman et al., MGI 114: Augmentation of antitumor activity when combined with topotecan, J PED H ONC, 22(4), 2000, pp. 306-314
Enhanced antitumour activity of 6-hydroxymethylacylfulvene in combination with topotecan or paclitaxel in the MV522 lung carcinoma xenograft model
Authors: Hammond, LA Hilsenbeck, SG Eckhardt, SG Marty, J Mangold, G MacDonald, JR Rowinsky, EK Von Hoff, DD Weitman, S
Citation: La. Hammond et al., Enhanced antitumour activity of 6-hydroxymethylacylfulvene in combination with topotecan or paclitaxel in the MV522 lung carcinoma xenograft model, EUR J CANC, 36(18), 2000, pp. 2430-2436
Phase I and pharmacokinetic study of irofulven, a novel mushroom-derived cytotoxin, administered for five consecutive days every four weeks in patients with advanced solid malignancies
Authors: Eckhardt, SG Baker, SD Britten, CD Hidalgo, M Siu, L Hammond, LA Villalona-Calero, MA Felton, S Drengler, R Kuhn, JG Clark, GM Smith, SL MacDonald, JR Smith, C Moczygemba, J Weitman, S Von Hoff, DD Rowinsky, EK
Citation: Sg. Eckhardt et al., Phase I and pharmacokinetic study of irofulven, a novel mushroom-derived cytotoxin, administered for five consecutive days every four weeks in patients with advanced solid malignancies, J CL ONCOL, 18(24), 2000, pp. 4086-4097
Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent
Authors: Mendel, DB Laird, AD Smolich, BD Blake, RA Liang, CX Hannah, AL Shaheen, RM Ellis, LM Weitman, S Shawver, LK Cherrington, JM
Citation: Db. Mendel et al., Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent, ANTI-CAN DR, 15(1), 2000, pp. 29-41
A phase I trial of bryostatin-1 in children with refractory solid tumors: A pediatric oncology group study
Authors: Weitman, S Langevin, AM Berkow, RL Thomas, PJ Hurwitz, CA Kraft, AS Dubowy, RL Smith, DL Bernstein, M
Citation: S. Weitman et al., A phase I trial of bryostatin-1 in children with refractory solid tumors: A pediatric oncology group study, CLIN CANC R, 5(9), 1999, pp. 2344-2348
Activity of SCH 66336, a tricyclic farnesyltransferase inhibitor, against human tumor colony-forming units
Authors: Petit, T Izbicka, E Lawrence, RA Bishop, WR Weitman, S Von Hoff, DD
Citation: T. Petit et al., Activity of SCH 66336, a tricyclic farnesyltransferase inhibitor, against human tumor colony-forming units, ANN ONCOL, 10(4), 1999, pp. 449-453
Activity of the multitargeted antifolate LY231514 in the human tumor cloning assay
Authors: Britten, CD Izbicka, E Hilsenbeck, S Lawrence, R Davidson, K Cerna, C Gomez, L Rowinsky, EK Weitman, S Von Hoff, DD
Citation: Cd. Britten et al., Activity of the multitargeted antifolate LY231514 in the human tumor cloning assay, CANC CHEMOT, 44(2), 1999, pp. 105-110
Evidence of enhanced in vivo activity using tirapazamine with paclitaxel and paraplatin regimens against the MV-522 human lung cancer xenograft
Authors: Weitman, S Mangold, G Marty, J Dexter, D Hilsenbeck, S Rake, J Juniewicz, P Von Hoff, D
Citation: S. Weitman et al., Evidence of enhanced in vivo activity using tirapazamine with paclitaxel and paraplatin regimens against the MV-522 human lung cancer xenograft, CANC CHEMOT, 43(5), 1999, pp. 402-408
Enhanced antitumor activity of 6-hydroxymethylacylfulvene in combination with irinotecan and 5-fluorouracil in the HT29 human colon tumor xenograft model
Authors: Britten, CD Hilsenbeck, SG Eckhardt, SG Marty, J Mangold, G MacDonald, JR Rowinsky, EK Von Hoff, DD Weitman, S
Citation: Cd. Britten et al., Enhanced antitumor activity of 6-hydroxymethylacylfulvene in combination with irinotecan and 5-fluorouracil in the HT29 human colon tumor xenograft model, CANCER RES, 59(5), 1999, pp. 1049-1053
Water soluble 20(S)-glycinate esters of 10,11-methylenedioxycamptothecins are highly active against human breast cancer xenografts
Authors: Wadkins, RM Potter, PM Vladu, B Marty, J Mangold, G Weitman, S Manikumar, G Wani, MC Wall, ME Von Hoff, DD
Citation: Rm. Wadkins et al., Water soluble 20(S)-glycinate esters of 10,11-methylenedioxycamptothecins are highly active against human breast cancer xenografts, CANCER RES, 59(14), 1999, pp. 3424-3428
On the elementary forms of the socioerotic life
Authors: Weitman, S
Citation: S. Weitman, On the elementary forms of the socioerotic life, THEOR CUL S, 15(3-4), 1998, pp. 71
Risultati: 1-17 |